![](/img/cover-not-exists.png)
Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies
Tan, Fenlai, Shen, Xiaoyan, Wang, Dechang, Xie, Guojian, Zhang, Xiaodong, Ding, Lieming, Hu, Yunyan, He, Wei, Wang, Yanping, Wang, YinxiangVolume:
76
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2011.10.023
Date:
May, 2012
File:
PDF, 580 KB
english, 2012